INmune Bio (INMB) Earnings (2018 - 2026)
INmune Bio (INMB) earnings from Mar 31, 2018 to Mar 31, 2026. The TTM INmune Bio (INMB) earnings is -$42M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
INmune Bio (INMB) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1.96% |
| 3 Years TTM | +15.60% |
| 5 Years TTM | +23.31% |
| All Time TTM | +20.18% |
Annual Earnings change of INmune Bio (INMB)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$5.41M | -88.22% |
| 2025 | -$46M | +9.15% |
| 2024 | -$42M | +40.22% |
| 2023 | -$30M | +9.93% |
| 2022 | -$27M | -10.02% |
| 2021 | -$30M | +150.74% |
| 2020 | -$12M | +57.55% |
| 2019 | -$7.68M | -38.26% |
| 2018 | -$12M | +1398.80% |
| 2017 | -$830K | N/A |
Comparison INmune Bio (INMB) five years earnings CAGR with competitors
INmune Bio (INMB) five years earnings CAGR is 23.32%.